Understanding GLP-1s for diabetes, weight loss, and beyond | Harvard Health Effects of Weight Loss on Lean Mass, Strength, Bone, and Aerobic Capacity | PMC Creatine supplementation with specific view to exercise/sports performance: an update | PMC
Because of the gap in our knowledge and the small absolute numbers seen in the trials, a systematic review and meta-analysis was conducted to determine if risks differ by indication (for diabetes vs weight loss), dose, or duration of treatment (4)
,
, Once-Weekly Semaglutide in Adults With Overweight or Obesity, New England Journal of Medicine 384, no
Researchers Yao et al
Exclusion criteria were central or nephrogenic diabetes insipidus (excluded by water deprivation test or hypertonic saline test), secondary polyuria (e.g., diabetes mellitus, hypokalemia, hypercalcemia), inability to follow the study procedures, e.g., because of an unstable psychiatric condition, a history of pancreatitis, or treatment with a GLP-1 RA within the previous 3 months
